Clinical Trials Logo
  1. Home
  2. Radiofrequency Ablation
  3. NCT03247413

Post-lesion Administration of Dexamethasone to Prevent the Development of Neuritis After Radiofrequency Ablation

Radiofrequency Ablation Clinical Trial

Official title:
Post-lesion Administration of Dexamethasone to Prevent the Development of Neuritis After Radiofrequency Ablation

Clinical Trial Summary

Chronic neck and back pain has become one of the leading causes of disability and loss of productivity. For many patients with facet or sacroiliac joint mediated pain who have responded to diagnostic nerve blocks, radiofrequency ablation of the nerves innervating the joints can provide long term relief. Radiofrequency ablation (RFA) is a relatively safe procedure with minimal risk of adverse events. However, with any procedure involving damage to the peripheral nervous system, there is risk of post-procedure neuropathic pain. The investigators will test the hypothesis that dexamethasone injection delivered at the time of lesion effectively prevents the development of post-ablation neuritis through a placebo-controlled, double-blind, randomized trial in patients undergoing cervical, thoracic, lumbar, and sacroiliac joint radiofrequency denervations

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Clinical Trial Details
NCT number NCT03247413
Study type Interventional
Source Johns Hopkins University
Contact
Status Terminated
Phase Phase 4
Start date September 1, 2019
Completion date October 14, 2022
View Details
See also
  Status Clinical Trial Phase
Not yet recruiting NCT04420013 - Colorectal Cancer Immunomonitoring Combined With Radiofrequency ablatIon
Completed NCT02382289 - Radiofrequency in Sacroiliac Arthropathy;Bipolar RF 6 Points Versus Monopolar RF at 6 and 3 Points N/A
Terminated NCT06371716 - Ex-vivo Ultrasound Guided Radiofrequency Ablation on Pancreatic Solid Lesions N/A
Recruiting NCT06033456 - Combining Stellate Ganglion and T2 and T3 Radiofrequency Ablation on Post-mastectomy Complex Regional Pain Syndrome N/A
Not yet recruiting NCT05559073 - Outcomes of Early Referral to Radiofrequency Ablation in Symptomatic Atrial Fibrillation Patients.
Completed NCT05078541 - Radiofrequency Ablation for Warthin's Tumor N/A
Recruiting NCT06003218 - Dexmedetomidine-esketamine for Percutaneous Radiofrequency Liver Ablation N/A
Recruiting NCT05500703 - Brain Regions and Functional Neuronal Network Characteristics of Dexmedetomidine Analgesia Phase 4
Completed NCT05719948 - Combined Continuous and Pulsed Radiofrequency Ablation for Pain Relief and Their Safety in Cervical Facet Pain N/A
Completed NCT03375281 - Radiofrequency Ablation Using Octopus Electrodes for Small Hepatocellular Carcinoma With No-touch Technique N/A
Recruiting NCT05142904 - Radiofrequency Ablation Versus I-131 for Solitary Autonomous Thyroid Nodules Phase 3
Recruiting NCT00750711 - Typical Flutter Ablation:A Comparison of 4 mm Versus 2 mm Irrigated cathéters N/A
Recruiting NCT02793479 - Radiofrequency Ablation in Patients With Barrett's Esophagus
Completed NCT01091597 - Pulmonary Vein (PV) Isolation Versus Box Isolation for the Treatment of Atrial Fibrillation N/A
Not yet recruiting NCT04417010 - To Identify KRAS Gene and Safe Margin in Association With Outcome in Colorectal Liver Metastases Following Ultrasound-guided Radiofrequency Ablation
Recruiting NCT03067493 - RFA or Surgical Resection Combined With Neo-MASCT for Primary HCC: a Phase II Trial Phase 2
Recruiting NCT04471272 - RFA Using Gradual RF Energy Delivery Mode With Octopus Electrodes N/A
Recruiting NCT04842253 - HFNC vs LFNC in Patients With AF Undergoing RFCA Under Deep Sedation. N/A
Completed NCT04801719 - Endoluminal Radiofrequency Ablation for the Treatment of Malignant Biliary Stenosis N/A
Recruiting NCT04331184 - RFA Using Combined Bipolar and Monopolar Energy Deliver With Twin Cooled-Wet Electrodes N/A